Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $2,290 | 2 | 77.0% |
| Travel and Lodging | $440.40 | 2 | 14.8% |
| Food and Beverage | $243.91 | 6 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sequoia Surgical, Inc. | $2,290 | 2 | $0 (2021) |
| Vericel Corporation | $610.82 | 6 | $0 (2017) |
| Smith & Nephew, Inc. | $49.15 | 1 | $0 (2017) |
| Next Science LLC | $24.34 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $1,224 | 2 | Sequoia Surgical, Inc. ($1,200) |
| 2017 | $1,750 | 8 | Sequoia Surgical, Inc. ($1,090) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2021 | Next Science LLC | SurgX (Device), Xperience | Food and Beverage | Cash or cash equivalent | $24.34 | General |
| Category: Surgical Site Infection | ||||||
| 03/12/2021 | Sequoia Surgical, Inc. | — | Education | In-kind items and services | $1,200.00 | General |
| 11/11/2017 | Sequoia Surgical, Inc. | — | Education | In-kind items and services | $1,090.00 | General |
| 06/17/2017 | Vericel Corporation | MACI (Drug) | Travel and Lodging | Cash or cash equivalent | $260.95 | General |
| Category: Cellular Therapy | ||||||
| 06/17/2017 | Vericel Corporation | MACI (Drug) | Travel and Lodging | Cash or cash equivalent | $179.45 | General |
| Category: Cellular Therapy | ||||||
| 06/17/2017 | Vericel Corporation | MACI (Drug) | Food and Beverage | Cash or cash equivalent | $86.98 | General |
| Category: Cellular Therapy | ||||||
| 06/17/2017 | Vericel Corporation | MACI (Drug) | Food and Beverage | Cash or cash equivalent | $37.03 | General |
| Category: Cellular Therapy | ||||||
| 06/17/2017 | Vericel Corporation | MACI (Drug) | Food and Beverage | Cash or cash equivalent | $25.18 | General |
| Category: Cellular Therapy | ||||||
| 06/17/2017 | Vericel Corporation | MACI (Drug) | Food and Beverage | Cash or cash equivalent | $21.23 | General |
| Category: Cellular Therapy | ||||||
| 01/24/2017 | Smith & Nephew, Inc. | Ambient Hipvac 50 (Device), Q-FIX | Food and Beverage | In-kind items and services | $49.15 | General |
| Category: Other Endoscopy | ||||||
About Dr. Thomas Powers, M.D
Dr. Thomas Powers, M.D is a Sports Medicine healthcare provider based in Elk Grove, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2009. The National Provider Identifier (NPI) number assigned to this provider is 1174755789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Powers, M.D has received a total of $2,974 in payments from pharmaceutical and medical device companies, with $1,224 received in 2021. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Education" ($2,290).
Practice Information
- Specialty Sports Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Orthopaedic Surgery
- Location Elk Grove, CA
- Active Since 08/14/2009
- Last Updated 12/17/2021
- Taxonomy Code 207XX0005X
- Entity Type Individual
- NPI Number 1174755789
Products in Payments
- MACI (Drug) $610.82
- Ambient Hipvac 50 (Device) $49.15
- SurgX (Device) $24.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.